Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control. Ngan, H. Y. S., Garland, S. M., Bhatla, N., Pagliusi, S. R., Chan, K. K. L., Cheung, A. N. Y., Chu, T. Y., Domingo, E. J., Qiao, Y. L., Park, J. S., Tay, E. H., & Supakarapongkul, W. Journal of Cancer Epidemiology, 2011.
Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control [link]Paper  doi  abstract   bibtex   
This paper aims to provide evidence-based recommendations for health professionals, to develop a comprehensive cervical cancer program for a clinic, a community, or a country. Ensuring access to healthcare is the responsibility of all societies, and the Asia Oceania Research Organisation in Genital Infections and Neoplasia (AOGIN) is committed to working collaboratively with governments and health professionals to facilitate prevention programs, to protect girls and women from cervical cancer, a disease that globally affects 500,000 and kills nearly 300,000 women annually, just over half of whom are in the Asia Oceania region. We share the vision that a comprehensive program of vaccination, screening, and treatment should be made accessible to all girls and women in the world. The primary purpose of these guidelines is to provide information on scientific evidence on the different modalities and approaches of cervical cancer prevention programs, for high resource and low resource settings. The secondary purpose is to provide an overview of the current situation of cervical cancer control and prevention in various Asian Oceania countries: their views of an ideal program, identified obstacles, and suggestions to overcome them are discussed. Copyright 2011 Hextan Y. S. Ngan et al.
@article{ngan_asia_2011,
	title = {Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control},
	issn = {1687-8558 1687-8566},
	url = {http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=361963079},
	doi = {10.1155/2011/794861},
	abstract = {This paper aims to provide evidence-based recommendations for health professionals, to develop a comprehensive cervical cancer program for a clinic, a community, or a country. Ensuring access to healthcare is the responsibility of all societies, and the Asia Oceania Research Organisation in Genital Infections and Neoplasia (AOGIN) is committed to working collaboratively with governments and health professionals to facilitate prevention programs, to protect girls and women from cervical cancer, a disease that globally affects 500,000 and kills nearly 300,000 women annually, just over half of whom are in the Asia Oceania region. We share the vision that a comprehensive program of vaccination, screening, and treatment should be made accessible to all girls and women in the world. The primary purpose of these guidelines is to provide information on scientific evidence on the different modalities and approaches of cervical cancer prevention programs, for high resource and low resource settings. The secondary purpose is to provide an overview of the current situation of cervical cancer control and prevention in various Asian Oceania countries: their views of an ideal program, identified obstacles, and suggestions to overcome them are discussed. Copyright 2011 Hextan Y. S. Ngan et al.},
	language = {English},
	journal = {Journal of Cancer Epidemiology},
	author = {Ngan, H. Y. S. and Garland, S. M. and Bhatla, N. and Pagliusi, S. R. and Chan, K. K. L. and Cheung, A. N. Y. and Chu, T. Y. and Domingo, E. J. and Qiao, Y. L. and Park, J. S. and Tay, E. H. and Supakarapongkul, W.},
	year = {2011},
	keywords = {*health program, *uterine cervix cancer/di [Diagnosis], *uterine cervix cancer/dt [Drug Therapy], *uterine cervix cancer/ep [Epidemiology], *uterine cervix cancer/pc [Prevention], *uterine cervix cancer/rt [Radiotherapy], *uterine cervix cancer/su [Surgery], Australia, China, Guillain Barre syndrome/si [Side Effect], Hong Kong, India, Papanicolaou test, Singapore, South Korea, Taiwan, Thailand, Wart virus vaccine/ae [Adverse Drug Reaction], Wart virus vaccine/cm [Drug Comparison], Wart virus vaccine/ct [Clinical Trial], Wart virus vaccine/dt [Drug Therapy], Wart virus vaccine/pe [Pharmacoeconomics], abdominal hysterectomy, antineoplastic agent/dt [Drug Therapy], arthralgia/si [Side Effect], cancer chemotherapy, cancer control, cancer incidence, cancer mortality, cancer prevention, cancer radiotherapy, cancer screening, colposcopy, condyloma acuminatum/dt [Drug Therapy], condyloma acuminatum/pc [Prevention], drug cost, drug efficacy, drug eruption/si [Side Effect], drug fever/si [Side Effect], drug induced headache/si [Side Effect], drug safety, fatigue/si [Side Effect], female, gastrointestinal symptom/si [Side Effect], government, health care access, health care personnel, health education, hepatitis B vaccine/ae [Adverse Drug Reaction], hepatitis B vaccine/cm [Drug Comparison], human, medical society, myalgia/si [Side Effect], postmarketing surveillance, practice guideline, primary prevention, priority journal, review, salpingooophorectomy, secondary prevention, urticaria/si [Side Effect], uterine cervix cancer/dt [Drug Therapy], uterine cervix carcinoma in situ/di [Diagnosis], uterine cervix cytology, vaccination, vaginal intraepithelial neoplasia/dt [Drug Therapy], vaginal intraepithelial neoplasia/pc [Prevention], venous thromboembolism/si [Side Effect]},
	pages = {794861},
}
Downloads: 0
About
Documentation
Keywords
Search
Users
Terms and Conditions of Use
Privacy Policy
Sitemap
© BibBase.org 2021